H. Parker
Président chez SANGAMO THERAPEUTICS, INC.
Fortune : 216 568 $ au 30/04/2024
Profil
H.
Stewart Parker is the founder of AmpliPhi Biosciences Corp., which was founded in 1992.
She held the title of Chief Executive Officer & Director from 1992 to 2008.
Ms. Parker's current job(s) include Chairman at Sangamo Therapeutics, Inc. since 2017, Independent Director at Codexis, Inc. since 2022, Director at Global Partnerships, Director at StrideBio, Inc. since 2018, Director at Inventprise LLC since 2018, and Principal at Parker Bioconsulting since 2009.
Ms. Parker's former job(s) include President, Chief Executive Officer & Director at Immunex Corp.
from 1981 to 2008, Chief Executive Officer & Director at Infectious Disease Research Institute from 2011 to 2014, Chairman at C3 Jian LLC, Chairman at C3J Therapeutics, Inc. from 2016 to 2019, President & Director at Receptech Corp.
from 1991 to 1993, Director at Neose Technologies, Inc. from 2005 to 2009, Director at Biotechnology Innovation Organization, Independent Director at Ipi Legacy Liquidation Co. from 2014 to 2023, Director at Nexgenia, Inc., Director at OncoGenex Technologies, Inc., Director at Regence BlueShield, Independent Director at OncoGenex Pharmaceuticals, Inc., Independent Director at Achieve Life Sciences, Inc. from 2010 to 2021, and Independent Director at Armata Pharmaceuticals, Inc. from 2019 to 2020.
Ms. Parker's education includes an undergraduate degree from the University of Washington in 1979 and an MBA in 1981.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CODEXIS, INC.
0,10% | 18/04/2024 | 72 480 ( 0,10% ) | 192 072 $ | 30/04/2024 |
| 08/04/2024 | 48 700 ( 0,02% ) | 24 496 $ | 30/04/2024 |
Postes actifs de H. Parker
| Sociétés | Poste | Début |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Président | 01/06/2017 |
| CODEXIS, INC. | Directeur/Membre du Conseil | 16/12/2022 |
Global Partnerships
 Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
| Parker Bioconsulting | Corporate Officer/Principal | 01/01/2009 |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Directeur/Membre du Conseil | 01/01/2018 |
Inventprise LLC
 Inventprise LLC Pharmaceuticals: MajorHealth Technology Inventprise LLC is a private company that is developing vaccines against infectious diseases, with a focus on invasive pneumococcal disease, using their innovative platform technology. The company is based in Redmond, WA. The company also offers contract services in biologics, including process development, optimization, analytical services, and manufacturing from early clinical trials through commercialization. The company was founded by Subhash Vinayak Kapre, who has been the CEO since incorporation. | Directeur/Membre du Conseil | 01/02/2018 |
Anciens postes connus de H. Parker
| Sociétés | Poste | Fin |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Directeur/Membre du Conseil | 10/04/2023 |
| ACHIEVE LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 11/05/2021 |
| ARMATA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/12/2020 |
| ░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de H. Parker
| University of Washington | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| ACHIEVE LIFE SCIENCES, INC. | Health Technology |
| ARMATA PHARMACEUTICALS, INC. | Health Technology |
| CODEXIS, INC. | Process Industries |
| Entreprise privées | 16 |
|---|---|
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Regence BlueShield
 Regence BlueShield Life/Health InsuranceFinance Regence BlueShield provides health insurance services. It also provides group and individual medical, dental and vision health insurance plans. The firm’s insurance products include HMO, supplemental Medicare and traditional indemnity. The company is headquartered in Seattle, WA. | Finance |
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to develop proprietary drugs, focusing primarily on therapeutic proteins. Its technologies to develop proprietary versions of protein drugs with proven safety and efficacy and to improve the therapeutic profiles of proteins being developed. Its proprietary drug development portfolio currently consists of two therapeutic protein candidates.GlycoPEG-EPO (NE-180) is a long-acting version of erythropoietin (EPO) produced in insect cells. EPO is prescribed to stimulate production of red blood cells, and it gives treatment of chemotherapy-induced anemia and anemia associated with chronic renal failure. Its second proprietary protein, GlycoPEG-GCSF, is a long-acting version of granulocyte colony stimulating factor G-CSF and it is prescribed to stimulate production of neutrophils (a type of white blood cell). Its trademarks are NEOSE, GlycoPEGylation and GlycoConjugation. It operates predominantly in the domestic market. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Health Technology |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA. | Health Technology |
Infectious Disease Research Institute
 Infectious Disease Research Institute Miscellaneous Commercial ServicesCommercial Services Infectious Disease Research Institute operates as a innovative science to research and development company. It offers pipeline, adjuvants, vaccines, diagnostics and drugs products. The firm also provides manufacturing, analytical methods, stability studies, process and contact services. The company was founded by Steven G. Reed in 1993 and is headquartered in Seattle, WA. | Commercial Services |
C3 Jian LLC
 C3 Jian LLC BiotechnologyHealth Technology C3 Jian, Inc. operates as a biotechnological research and development company. It provides development and commercialization of pathogen-specific and antimicrobials that treat and prevent diseases caused by microbial dysbiosis. The company is headquartered in Marina del Rey, CA. | Health Technology |
Receptech Corp.
 Receptech Corp. Medical DistributorsDistribution Services Part of Amgen, Inc., Receptech Corp. is a company that sells Immunex products. The company is based in Seattle, WA. Receptech was acquired by Immunex Corp., part of Amgen, Inc. from July 16, 2002 on December 16, 1992 for $59.40 million. | Distribution Services |
Nexgenia, Inc.
 Nexgenia, Inc. Medical SpecialtiesHealth Technology Nexgenia, Inc. develops molecule-specific selection reagents. Its technology include polymer-protein conjugates and magnetic nanoparticles. The company was founded by James Lai and Thomas Schulte in February 2011 and is headquartered in Seattle, WA. | Health Technology |
Global Partnerships
Global Partnerships Financial ConglomeratesFinance Global Partnerships invests in partnerships with local organizations that use market-based solutions for people living in poverty. The firm invests in the areas such as health services, rural livelihoods, green technology and microentrepreneurship. The company was founded by Paula Clapp and Bill Clapp in 1994 and is headquartered in Seattle, WA. | Finance |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology C3J Therapeutics, Inc. operates as a biotechnology company. It focuses on the discovery and development of novel targeted antimicrobials-synthetic bacteriophage and antimicrobial peptides. The company was founded by Randal Eckert, Maxwell H. Anderson and Wenyuan Shi in 2005 and is headquartered in Marina del Rey, CA. | Health Technology |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Health Technology |
| Parker Bioconsulting | |
OncoGenex Technologies, Inc.
 OncoGenex Technologies, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Technologies, Inc. develops drugs for cancer patients. Its products are being developed to block the production of specific proteins associated with the development of treatment resistance which will increase survival time and improve the quality of life for cancer patients. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Health Technology |
Inventprise LLC
Inventprise LLC Pharmaceuticals: MajorHealth Technology Inventprise LLC is a private company that is developing vaccines against infectious diseases, with a focus on invasive pneumococcal disease, using their innovative platform technology. The company is based in Redmond, WA. The company also offers contract services in biologics, including process development, optimization, analytical services, and manufacturing from early clinical trials through commercialization. The company was founded by Subhash Vinayak Kapre, who has been the CEO since incorporation. | Health Technology |
